Correlation Between Pliant Therapeutics and Immunocore Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Immunocore Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Immunocore Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Immunocore Holdings, you can compare the effects of market volatilities on Pliant Therapeutics and Immunocore Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Immunocore Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Immunocore Holdings.

Diversification Opportunities for Pliant Therapeutics and Immunocore Holdings

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pliant and Immunocore is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Immunocore Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunocore Holdings and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Immunocore Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunocore Holdings has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Immunocore Holdings go up and down completely randomly.

Pair Corralation between Pliant Therapeutics and Immunocore Holdings

Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Immunocore Holdings. In addition to that, Pliant Therapeutics is 1.23 times more volatile than Immunocore Holdings. It trades about -0.12 of its total potential returns per unit of risk. Immunocore Holdings is currently generating about 0.02 per unit of volatility. If you would invest  3,202  in Immunocore Holdings on August 24, 2024 and sell it today you would earn a total of  10.00  from holding Immunocore Holdings or generate 0.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pliant Therapeutics  vs.  Immunocore Holdings

 Performance 
       Timeline  
Pliant Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pliant Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Pliant Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Immunocore Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunocore Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pliant Therapeutics and Immunocore Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pliant Therapeutics and Immunocore Holdings

The main advantage of trading using opposite Pliant Therapeutics and Immunocore Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Immunocore Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunocore Holdings will offset losses from the drop in Immunocore Holdings' long position.
The idea behind Pliant Therapeutics and Immunocore Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.